RBC Capital Lifts HCA Healthcare, Inc. (HCA) Price Target Following Robust Revenue and Earnings Growth

By Abdul Rahman | November 14, 2025, 11:50 PM

HCA Healthcare Inc. (NYSE:HCA) is one of the best blue-chip stocks to buy now. On October 27, analysts at RBC Capital reiterated an Outperform rating on HCA Healthcare Inc. (NYSE:HCA) and raised the price target to $482 from $449. The price target was raised following the company’s strong third‑quarter results, reported on October 24, which came in ahead of expectations.

RBC Capital Lifts HCA Healthcare, Inc. (HCA) Price Target Following Robust Revenue and Earnings Growth

Revenues in the quarter increased 9.6% year over year to $19.16 billion as net income increased 29.4% to $1.64 billion. Diluted earnings per share increased 42.6% to $6.96 per diluted share. RBC Capital increased its price target after management raised its full-year guidance.

Management expects revenue to range between $75 billion and $76.45 billion, up from the previous guidance of $74.00 billion to $76.00 billion. Net income attributed to shareholders is expected to be between $6.495 billion and $6.715 billion, up from the prior guidance of $6.110 billion to $6.480 billion. Earnings per share are expected to range between $27.00 $28.00 per diluted share, up from the previous guidance of between $25.50 and $27.00 per diluted share.

According to RBC Capital, the strong Q3 performance and guidance upgrade affirm management’s confidence in achieving volume growth in line with long-term targets. The research firm expects strong demographics and expanded patient access to support HCA’s growth prospects in 2026.

HCA Healthcare, Inc. (NYSE:HCA) is a private healthcare provider, operating a vast network of hospitals, outpatient facilities, and other healthcare sites.

While we acknowledge the potential of HCA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 9 Undervalued Asset Management Stocks to Buy and 13 Best AI Stocks to Buy Under $20.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News

Nov-14
Nov-13
Nov-13
Nov-13
Nov-12
Nov-12
Nov-12
Nov-12
Nov-11
Nov-11
Nov-11
Nov-10
Nov-10
Nov-10
Nov-10